VRTX vs AMZN: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

VRTX has stronger fundamentals based on our AI analysis.

VRTX
VERTEX PHARMACEUTICALS INC / MA
BUY
86%
Confidence
VS
AMZN
AMAZON COM INC
BUY
81%
Confidence

VRTX vs AMZN Fundamental Comparison

Metric VRTX AMZN
Revenue $12.0B $716.9B
Net Income $4.0B $77.7B
Net Margin 32.9% 10.8%
ROE 21.2% 18.9%
ROA 15.4% 9.5%
Current Ratio 2.90x 1.05x
Debt/Equity 0.01x 0.17x
EPS $15.32 $7.17

Green = Better metric | Red = Weaker metric

View Full VRTX Analysis →
View Full AMZN Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

VRTX vs AAPL AMZN vs MSFT VRTX vs GOOGL AMZN vs NVDA

VRTX vs AMZN: Frequently Asked Questions

Is VRTX or AMZN a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), VRTX has stronger fundamentals. VRTX is rated BUY (86% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.

How does VRTX compare to AMZN fundamentally?

VERTEX PHARMACEUTICALS INC / MA has ROE of 21.2% vs AMAZON COM INC's 18.9%. Net margins are 32.9% vs 10.8% respectively.

Which stock pays higher dividends, VRTX or AMZN?

VRTX has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in VRTX or AMZN for long term?

For long-term investing, consider that VRTX has BUY rating with 86% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about VRTX vs AMZN?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For VRTX vs AMZN, the AI consensus favors VRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.